Issues and Updates in Emerging Neurologic Viral Infections

Michael R Wilson; Kenneth L Tyler

doi:10.1055/s-0031-1287650

Seminars in Neurology, Table of Contents

Semin Neurol 2011; 31(3): 245-253
DOI: 10.1055/s-0031-1287650

Issues and Updates in Emerging Neurologic Viral Infections

Michael R. Wilson¹ ^, ² ^, ³ , Kenneth L. Tyler⁴ ^, ⁵

¹Department of Neurology, Massachusetts General Hospital, Boston, Massachusetts
²Department of Neurology, Brigham and Women's Hospital, Boston, Massachusetts
³Harvard Medical School, Boston, Massachusetts
⁴Department of Neurology, Medicine (Infectious Diseases) and Microbiology, University of Colorado Denver Health Sciences Center, Aurora, Colorado
⁵Department of Neurology Service Denver Veterans Affairs Medical Center, Aurora, Colorado

Abstract

ABSTRACT

This review discusses the recent advances in the identification of viral pathogens and other etiologies responsible for cases of suspected viral encephalitis. The authors describe new molecular diagnostic strategies for identifying novel causes of viral encephalitis, including MassTag PCR, DNA microarrays, and high-throughput DNA pyrosequencing. They also highlight the increasing recognition of immune-mediated causes of encephalitis among those cases previously thought to be viral encephalitis of unknown etiology. Lastly, they review some of the most recent updates in the field of emerging neurologic viral infections impacting the United States, including the neurologic complications of H1N1 virus and the reemergence of dengue virus in the Florida Keys.

KEYWORDS

Viral encephalitis - MassTag PCR - DNA microarray - high-throughput DNA pyrosequencing - dengue fever - H1N1 influenza virus - autoimmune encephalitis

Full Text

References

REFERENCES

1 Tyler K L. Emerging viral infections of the central nervous system: part 1. Arch Neurol. 2009; 66 (8) 939-948
2 Tyler K L. Emerging viral infections of the central nervous system: part 2. Arch Neurol. 2009; 66 (9) 1065-1074
3 Griffin D E. Emergence and re-emergence of viral diseases of the central nervous system. Prog Neurobiol. 2010; 91 (2) 95-101
4 Glaser C A, Gilliam S, Schnurr D California Encephalitis Project, 1998-2000 et al. In search of encephalitis etiologies: diagnostic challenges in the California Encephalitis Project, 1998-2000. Clin Infect Dis. 2003; 36 (6) 731-742
5 Glaser C A, Honarmand S, Anderson L J et al.. Beyond viruses: clinical profiles and etiologies associated with encephalitis. Clin Infect Dis. 2006; 43 (12) 1565-1577
6 Granerod J, Tam C C, Crowcroft N S, Davies N WS, Borchert M, Thomas S L. Challenge of the unknown. A systematic review of acute encephalitis in non-outbreak situations. Neurology. 2010; 75 (10) 924-932
7 Lipkin W I. Microbe hunting in the 21st century. Proc Natl Acad Sci U S A. 2009; 106 (1) 6-7
8 Lipkin W I. Pathogen discovery. PLoS Pathog. 2008; 4 (4) e1000002
9 Briese T, Palacios G, Kokoris M et al.. Diagnostic system for rapid and sensitive differential detection of pathogens. Emerg Infect Dis. 2005; 11 (2) 310-313
10 Lamson D, Renwick N, Kapoor V et al.. MassTag polymerase-chain-reaction detection of respiratory pathogens, including a new rhinovirus genotype, that caused influenza-like illness in New York State during 2004-2005. J Infect Dis. 2006; 194 (10) 1398-1402
11 Palacios G, Briese T, Kapoor V et al.. MassTag polymerase chain reaction for differential diagnosis of viral hemorrhagic fever. Emerg Infect Dis. 2006; 12 (4) 692-695
12 Dominguez S R, Briese T, Palacios G et al.. Multiplex MassTag-PCR for respiratory pathogens in pediatric nasopharyngeal washes negative by conventional diagnostic testing shows a high prevalence of viruses belonging to a newly recognized rhinovirus clade. J Clin Virol. 2008; 43 (2) 219-222
13 Wang D, Coscoy L, Zylberberg M et al.. Microarray-based detection and genotyping of viral pathogens. Proc Natl Acad Sci U S A. 2002; 99 (24) 15687-15692
14 Wang D, Urisman A, Liu Y T et al.. Viral discovery and sequence recovery using DNA microarrays. PLoS Biol. 2003; 1 (2) E2
15 Chiu C Y, Urisman A, Greenhow T L et al.. Utility of DNA microarrays for detection of viruses in acute respiratory tract infections in children. J Pediatr. 2008; 153 (1) 76-83
16 Ksiazek T G, Erdman D, Goldsmith C S SARS Working Group et al. A novel coronavirus associated with severe acute respiratory syndrome. N Engl J Med. 2003; 348 (20) 1953-1966
17 Urisman A, Molinaro R J, Fischer N et al.. Identification of a novel gammaretrovirus in prostate tumors of patients homozygous for R462Q RNASEL variant. PLoS Pathog. 2006; 2 (3) e25
18 Chiu C Y, Greninger A L, Kanada K et al.. Identification of cardioviruses related to Theiler's murine encephalomyelitis virus in human infections. Proc Natl Acad Sci U S A. 2008; 105 (37) 14124-14129
19 Kistler A L, Gancz A, Clubb S et al.. Recovery of divergent avian bornaviruses from cases of proventricular dilatation disease: identification of a candidate etiologic agent. Virol J. 2008; 5 88
20 Palacios G, Druce J, Du L et al.. A new arenavirus in a cluster of fatal transplant-associated diseases. N Engl J Med. 2008; 358 (10) 991-998
21 Quan P L, Wagner T A, Briese T et al.. Astrovirus encephalitis in boy with X-linked agammaglobulinemia. Emerg Infect Dis. 2010; 16 (6) 918-925
22 Tunkel A R, Glaser C A, Bloch K C Infectious Diseases Society of America et al. The management of encephalitis: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis. 2008; 47 (3) 303-327
23 Vincent A, Buckley C, Schott J M et al.. Potassium channel antibody-associated encephalopathy: a potentially immunotherapy-responsive form of limbic encephalitis. Brain. 2004; 127 (Pt 3) 701-712
24 Dalmau J, Lancaster E, Martinez-Hernandez E, Rosenfeld M R, Balice-Gordon R. Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis. Lancet Neurol. 2011; 10 (1) 63-74
25 Darnell R B, Posner J B. Paraneoplastic syndromes affecting the nervous system. Semin Oncol. 2006; 33 (3) 270-298
26 Jarius S, Hoffmann L A, Stich O et al.. Relative frequency of VGKC and ‘classical’ paraneoplastic antibodies in patients with limbic encephalitis. J Neurol. 2008; 255 (7) 1100-1101
27 Dalmau J, Gleichman A J, Hughes E G et al.. Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies. Lancet Neurol. 2008; 7 (12) 1091-1098
28 Prüss H, Dalmau J, Harms L et al.. Retrospective analysis of NMDA receptor antibodies in encephalitis of unknown origin. Neurology. 2010; 75 (19) 1735-1739
29 Gable M S, Gavali S, Radner A et al.. Anti-NMDA receptor encephalitis: report of ten cases and comparison with viral encephalitis. Eur J Clin Microbiol Infect Dis. 2009; 28 (12) 1421-1429
30 de Jong M D, Bach V C, Phan T Q et al.. Fatal avian influenza A (H5N1) in a child presenting with diarrhea followed by coma. N Engl J Med. 2005; 352 (7) 686-691
31 Bautista E, Chotpitayasunondh T, Gao Z Writing Committee of the WHO Consultation on Clinical Aspects of Pandemic (H1N1) 2009 Influenza et al. Clinical aspects of pandemic 2009 influenza A (H1N1) virus infection. N Engl J Med. 2010; 362 (18) 1708-1719
32 Centers for Disease Control and Prevention .CDC Estimates of 2009 H1N1 Influenza Cases, Hospitalizations and Deaths in the United States, April 2009–March 13, 2010. Available at: http://www.flu.gov/individualfamily/about/h1n1/estimates_2009_h1n1.html Accessed August 26, 2011
33 Rellosa N, Bloch K C, Shane A L, Debiasi R L. Neurologic manifestations of pediatric novel h1n1 influenza infection. Pediatr Infect Dis J. 2011; 30 (2) 165-167
34 Fugate J E, Lam E M, Rabinstein A A, Wijdicks E FM. Acute hemorrhagic leukoencephalitis and hypoxic brain injury associated with H1N1 influenza. Arch Neurol. 2010; 67 (6) 756-758
35 Denholm J T, Neal A, Yan B et al.. Acute encephalomyelitis syndromes associated with H1N1 09 influenza vaccination. Neurology. 2010; 75 (24) 2246-2248
36 Schonberger L B, Bregman D J, Sullivan-Bolyai J Z et al.. Guillain-Barre syndrome following vaccination in the National Influenza Immunization Program, United States, 1976–1977. Am J Epidemiol. 1979; 110 (2) 105-123
37 Centers for Disease Control and Prevention (CDC) . Preliminary results: surveillance for Guillain-Barré syndrome after receipt of influenza A (H1N1) 2009 monovalent vaccine—United States, 2009-2010. MMWR Morb Mortal Wkly Rep. 2010; 59 (21) 657-661
38 Vellozzi C, Broder K R, Haber P et al.. Adverse events following influenza A (H1N1) 2009 monovalent vaccines reported to the Vaccine Adverse Event Reporting System, United States, October 1, 2009-January 31, 2010. Vaccine. 2010; 28 (45) 7248-7255
39 Gibbons R V, Vaughn D W. Dengue: an escalating problem. BMJ. 2002; 324 (7353) 1563-1566
40 Domingues R B, Kuster G W, Onuki-Castro F L, Souza V A, Levi J E, Pannuti C S. Involvement of the central nervous system in patients with dengue virus infection. J Neurol Sci. 2008; 267 (1-2) 36-40
41 Soares C N, Faria L C, Peralta J M, de Freitas M RG, Puccioni-Sohler M. Dengue infection: neurological manifestations and cerebrospinal fluid (CSF) analysis. J Neurol Sci. 2006; 249 (1) 19-24
42 Kankirawatana P, Chokephaibulkit K, Puthavathana P, Yoksan S, Apintanapong S, Pongthapisit V. Dengue infection presenting with central nervous system manifestation. J Child Neurol. 2000; 15 (8) 544-547
43 Solomon T, Dung N M, Vaughn D W et al.. Neurological manifestations of dengue infection. Lancet. 2000; 355 (9209) 1053-1059
44 Centers for Disease Control and Prevention (CDC) . Locally acquired Dengue—Key West, Florida, 2009-2010. MMWR Morb Mortal Wkly Rep. 2010; 59 (19) 577-581

Kenneth L TylerM.D.

Neurology B-182, Research Complex-2, University of Colorado Denver Health Sciences Center

12700 East 19th Avenue, Aurora, CO 80045

Email: Ken.Tyler@ucdenver.edu